رجوع

Watch Compare

RESMED INC

جودة البيانات: 100%

RSMDF

NYSE Manufacturing Measuring & Analyzing Instruments

KWD 24.89

▲ KWD 5.23 (26.60%)

القيمة السوقية: 28.64 B

السعر

KWD 19.66

القيمة السوقية

28.64 B

نطاق اليوم

—

نطاق 52 أسبوعًا

—

حجم التداول

—

فتح —

متوسط 50 يوم / 200 يوم

—

متوسط 50 يوم / 200 يوم

—

Quick Summary

النقاط الرئيسية

Revenue grew 12.64% annually over 5 years — strong growth

Earnings grew 37.20% over the past year

ROE of 23.88% indicates high profitability

Net margin of 27.53% shows strong profitability

Debt/Equity of 0.11 — conservative balance sheet

Generating 1.79 B in free cash flow

النمو

Revenue Growth (5Y)

12.64%

أعلى من متوسط القطاع (1.82%)

Revenue (1Y)9.84%

Earnings (1Y)37.20%

FCF Growth (3Y)70.20%

الجودة

Return on Equity

23.88%

أعلى من متوسط القطاع (-54.47%)

ROIC20.05%

Net Margin27.53%

Op. Margin33.70%

الأمان

Debt / Equity

0.11

أقل من متوسط القطاع (0.30)

Current Ratio3.06

Interest CoverageN/A

التقييم

PE (TTM|NTM)

19.28 | 60.71

أعلى من متوسط القطاع (-1.49)

P/B Ratio4.53

EV/EBITDA13.78

Dividend Yield1.19%

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1385 نظير)

المقياس	السهم	وسيط القطاع
P/E	19.3	-1.5
P/B	4.5	1.6
ROE %	23.9	-54.5
Net Margin %	27.5	-41.5
Rev Growth 5Y %	12.6	1.8
D/E	0.1	0.3

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة	تقدير ربحية السهم	تقدير الإيرادات	المحللون
FY2027	—	6.06 B	—
FY2026	—	5.64 B	—

الفترة	تقدير ربحية السهم	تقدير الإيرادات	المحللون
2026 Q2	—	1.46 B	—
2026 Q1	—	1.42 B	—

Dividend History

12 yr streak

Yield

1.19%

Payout Ratio

2.30%

Growth (3Y)

9.53%

Growth (5Y)

14.07%

Ex-Date	Payment Date	Amount	Yield
Feb 11, 2026	—	KWD 0.06	N/A
Nov 12, 2025	—	KWD 0.06	N/A
Aug 13, 2025	—	KWD 0.06	N/A
May 07, 2025	—	KWD 0.05	N/A
Feb 12, 2025	—	KWD 0.05	N/A
Nov 06, 2024	—	KWD 0.05	N/A
Aug 14, 2024	—	KWD 0.05	N/A
May 08, 2024	—	KWD 0.05	N/A
Feb 07, 2024	—	KWD 0.05	N/A
Nov 08, 2023	—	KWD 0.05	N/A
Aug 16, 2023	—	KWD 0.05	N/A
May 10, 2023	—	KWD 0.04	N/A
Feb 08, 2023	—	KWD 0.04	N/A
Nov 09, 2022	—	KWD 0.04	N/A
Aug 17, 2022	—	KWD 0.04	N/A
May 11, 2022	—	KWD 0.04	N/A
Feb 09, 2022	—	KWD 0.04	N/A
Nov 10, 2021	—	KWD 0.04	N/A
Aug 18, 2021	—	KWD 0.04	N/A
May 12, 2021	—	KWD 0.04	N/A

All Fundamental Metrics

Growth
Revenue Growth (1Y)	9.84%	Revenue Growth (3Y)	10.39%
Earnings Growth (1Y)	37.20%	Earnings Growth (3Y)	24.92%
Revenue Growth (5Y)	12.64%	Earnings Growth (5Y)	31.08%
Profitability
Revenue (TTM)	5.40 B	Net Income (TTM)	1.49 B
ROE	23.88%	ROA	17.68%
Gross Margin	60.87%	Operating Margin	33.70%
Net Margin	27.53%	Free Cash Flow (TTM)	1.79 B
ROIC	20.05%	FCF Growth (3Y)	70.20%
Safety
Debt / Equity	0.11	Current Ratio	3.06
Interest Coverage	N/A	Asset Turnover	0.64
Working Capital	2.57 B	Tangible Book Value	2.85 B
Dividends
Dividend Yield	1.19%	Payout Ratio	2.30%
Dividend Growth (3Y)	9.53%	Dividend Growth (5Y)	14.07%
Consecutive Div Years	12 yrs
Valuation
P/E Ratio	19.28	Forward P/E	60.71
P/B Ratio	4.53	P/S Ratio	5.31
PEG Ratio	0.62	Forward PEG	N/A
EV/EBITDA	13.78	Fwd EV/EBITDA	N/A
Forward P/S	4.72	Fwd Earnings Yield	1.65%
FCF Yield	6.26%
Market Cap	28.64 B	Enterprise Value	27.89 B
Per Share
EPS (Diluted TTM)	10.11	Revenue / Share	3.71
FCF / Share	1.23	OCF / Share	1.31
EPS CAGR (1Y)	37.43%	EPS CAGR (5Y)	30.89%
EPS CAGR (10Y)	16.06%
Efficiency
CapEx / Revenue	2.28%	FCF Conversion	120.58%
SBC-Adj. FCF	1.70 B	Growth Momentum	-2.80

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	5.15 B	4.69 B	4.22 B	3.58 B	3.20 B
Net Income	1.40 B	1.02 B	897.56 M	779.44 M	474.51 M
EPS (Diluted)	9.51	6.92	6.09	5.30	3.24
Gross Profit	3.05 B	2.66 B	2.36 B	2.02 B	1.84 B
Operating Income	1.69 B	1.32 B	1.13 B	1.00 B	903.68 M
EBITDA	—	—	—	—	—
R&D Expenses	331.28 M	307.53 M	287.64 M	253.58 M	225.28 M
SG&A Expenses	991.02 M	917.14 M	874.00 M	739.37 M	670.39 M
D&A	198.47 M	176.87 M	165.16 M	159.61 M	156.76 M
Interest Expense	—	—	-47.38 M	-22.31 M	23.99 M
Income Tax	276.84 M	243.85 M	204.11 M	181.05 M	409.16 M

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	8.17 B	6.87 B	6.75 B	5.10 B	4.73 B
Total Liabilities	2.21 B	2.01 B	2.62 B	1.74 B	1.84 B
Shareholders' Equity	5.97 B	4.86 B	4.13 B	3.36 B	2.89 B
Total Debt	668.29 M	707.21 M	1.44 B	775.24 M	655.35 M
Cash & Equivalents	1.21 B	238.36 M	227.89 M	273.71 M	295.28 M
Current Assets	3.51 B	2.36 B	2.37 B	1.93 B	1.57 B
Current Liabilities	1.02 B	910.66 M	758.53 M	689.30 M	911.77 M